The financial burden of destination left ventricular assist device therapy: Who and when?
- 1 May 2007
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 9 (3) , 194-199
- https://doi.org/10.1007/bf02938350
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart FailureNew England Journal of Medicine, 2006
- Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart FailureThe Journal of Heart and Lung Transplantation, 2006
- Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic TherapyCirculation, 2004
- Medicare Reimbursement for Destination TherapyArtificial Organs, 2004
- Medicare Reimbursement for Destination Therapy: The Right Decision at the Right Time?Artificial Organs, 2004
- Left Ventricular Assist Devices as Permanent Heart Failure TherapyAnnals of Surgery, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- Economics of devicesThe Annals of Thoracic Surgery, 2001
- The epidemiology of heart failure: The Framingham StudyJournal of the American College of Cardiology, 1993
- Medicare and Heart Transplants: Will Lightning Strike Twice?Health Affairs, 1988